Results 221 to 230 of about 1,649,429 (264)
Some of the next articles are maybe not open access.
2015 And Human Cancer: Back to Overall Survival
Future Oncology, 201610.2217/fon-2015-0085 © 2016 Future Medicine Ltd At the end of the year, it is time to take stock. What has been the revolutionary innovation in oncology in 2015? Key steps in translational research are certainly strengthening the foundations of cancer knowledge. As genome sequencing has allowed outlining the mutational landscape of several tumor types
Ciccarese C., Massari F., Tortora G.
openaire +3 more sources
FOXP3 Expression and Overall Survival in Breast Cancer
Journal of Clinical Oncology, 2009PurposeThe transcription factor forkhead box P3 (FOXP3) up- or downregulates a large number of genes and has been recently reported to be expressed in tumor cells. We investigated the prognostic importance of FOXP3 expression in patients with breast cancer.Patients and MethodsThe expression patterns of FOXP3 were characterized by immunohistochemistry ...
A. Merlo +7 more
openaire +2 more sources
Recombinant human erythropoietin and overall survival
Current Oncology Reports, 2005Although a trend was seen for increased thromboembolic events in patients treated with erythropoietin, there was also a trend for improved survival times in such patients.
openaire +2 more sources
Radiogenomics model for overall survival prediction of glioblastoma
Medical & Biological Engineering & Computing, 2020Glioblastoma multiforme (GBM) is a very aggressive and infiltrative brain tumor with a high mortality rate. There are radiomic models with handcrafted features to estimate glioblastoma prognosis. In this work, we evaluate to what extent of combining genomic with radiomic features makes an impact on the prognosis of overall survival (OS) in patients ...
Navodini Wijethilake +2 more
openaire +2 more sources
Brain Metastases: Surgical Treatment and Overall Survival
World Neurosurgery, 2017Brain metastases occur in 10%-40% of patients with cancer and are more common than primary brain tumors (30%-40%); their incidence is growing because of improvements in control of systemic disease, better radiologic detection, and prolonged survival. Modern treatment of brain metastases has dramatically changed the expected prognosis.
D(')Andrea, G. +4 more
openaire +6 more sources
Overall survival in TP53-mutated AML and MDS
Annals of HematologyTP53 mutations in patients with AML and MDS frequently portend a poor prognosis, related to both p53 allele status and blast count. In 2022, the ICC and WHO released updated guidelines for classifying p53-mutated AML/MDS. The characteristics of p53 mutations, their associated co-mutations, and their effects on overall survival (OS) are not known in the
Christian J. Puzo +4 more
openaire +2 more sources
Health insurance status and cancer stage at diagnosis and survival in the United States
Ca-A Cancer Journal for Clinicians, 2022Leticia Nogueira +2 more
exaly
Overall Survival vs Disease-Specific Survival—Reply
JAMA Oncology, 2018Sham, Mailankody, Vinay, Prasad
openaire +2 more sources